MarketPulse

plan of arrangement

7 articles
BenzingaBenzinga··Prnewswire

Fairfax Financial Backs Eldorado-Foran Merger to Create Canadian Mining Powerhouse

Fairfax Financial backs Eldorado-Foran mining merger, voting 17.6% stake in favor. Position expands to 21.6% post-conversion, significantly de-risking shareholder approval.
EGOcritical mineralsshareholder approval
GlobeNewswire Inc.GlobeNewswire Inc.··Nicholas Luksha

Mustang Energy Completes Uranium Asset Spinoff, Allied Strategic Launches on CSE

Mustang Energy spins off uranium assets into Allied Strategic Resource Corp., which receives conditional CSE approval under ticker 'ASR'. Shareholders receive new shares in both entities.
MECPFspin-offSaskatchewan
GlobeNewswire Inc.GlobeNewswire Inc.··Na

ISS and Glass Lewis Back Allied Gold's $44/Share Zijin Takeover Deal

Top proxy advisors ISS and Glass Lewis recommend Allied Gold shareholders approve Zijin's C$44/share acquisition. Shareholder vote scheduled for March 31, 2026.
AAUCgold miningmerger and acquisition
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Falcon Oil & Gas Wins Overwhelming Shareholder Backing for Tamboran Deal

Falcon Oil & Gas shareholders overwhelmingly approved a Tamboran merger with 99.76% support, clearing the way for completion by mid-March 2026.
TBNNYSE listingshareholder approval
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Quipt Home Medical Approved for US$3.65/Share Buyout, Delisting Expected by March 2026

Quipt Home Medical gains final court approval for US$3.65/share acquisition by Kingswood and Forager Capital affiliates, with delisting expected by March 2026.
QIPTacquisitiondelisting
BenzingaBenzinga··Globe Newswire

Quipt Home Medical Approved for US$3.65/Share Buyout, Delisting Expected by March 2026

Quipt Home Medical receives final court approval for US$3.65/share acquisition by Kingswood and Forager Capital affiliates, with delisting expected by March 2026.
QIPTacquisitiondelisting
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Quipt Home Medical Shareholders Overwhelmingly Approve $3.65/Share Buyout

Quipt Home Medical shareholders voted 98.9% in favor of acquisition by Kingswood and Forager Capital for US$3.65 per share, with court approval expected March 5, 2026.
QIPTacquisitionregulatory approval